Search by Drug Name or NDC
NDC 49702-0250-18 Rukobia 600 mg/1 Details
Rukobia 600 mg/1
Rukobia is a ORAL TABLET, FILM COATED, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by ViiV Healthcare Company. The primary component is FOSTEMSAVIR TROMETHAMINE.
MedlinePlus Drug Summary
Fostemsavir is used along with other medications to treat human immunodeficiency virus (HIV) infection in adults whose HIV could not be successfully treated with other medications, including their current therapy. Fostemsavir is in a class of medications called HIV attachment inhibitors. It works by decreasing the amount of HIV in the blood. Although fostemsavir does not cure HIV, it may decrease your chance of developing acquired immunodeficiency syndrome (AIDS) and HIV-related illnesses such as serious infections or cancer. Taking these medications along with practicing safer sex and making other life-style changes may decrease the risk of transmitting (spreading) the HIV virus to other people.
Related Packages: 49702-0250-18Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Fostemsavir
Product Information
| NDC | 49702-0250 |
|---|---|
| Product ID | 49702-250_ba7411e4-dc14-4225-9ed0-2931a229fd61 |
| Associated GPIs | 12102330407420 |
| GCN Sequence Number | 081260 |
| GCN Sequence Number Description | fostemsavir tromethamine TAB ER 12H 600 MG ORAL |
| HIC3 | W50 |
| HIC3 Description | ANTIVIRALS, HIV-SPECIFIC, CD4 ATTACHMENT INHIBITOR |
| GCN | 48315 |
| HICL Sequence Number | 046684 |
| HICL Sequence Number Description | FOSTEMSAVIR TROMETHAMINE |
| Brand/Generic | Brand |
| Proprietary Name | Rukobia |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | fostemsavir tromethamine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED, EXTENDED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 600 |
| Active Ingredient Units | mg/1 |
| Substance Name | FOSTEMSAVIR TROMETHAMINE |
| Labeler Name | ViiV Healthcare Company |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA212950 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 49702-0250-18 (49702025018)
| NDC Package Code | 49702-250-18 |
|---|---|
| Billing NDC | 49702025018 |
| Package | 1 BOTTLE in 1 CARTON (49702-250-18) / 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE |
| Marketing Start Date | 2020-07-02 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |